IronBridge Capital Management’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
TCM
O
CCA
RIM
IronBridge Capital Management's RGEN Position: Q1 2017 in Review
IronBridge Capital Management increased its Repligen (RGEN) stake by 74% in Q1 2017, buying an estimated $2.88M and bringing the position to 212,822 shares worth $7.49M. The position accounts for 0.45% of the portfolio, ranked #75.
IronBridge Capital Management first reported a position in RGEN in Q2 2016 and has held it in 4 quarters since. 180 funds tracked by Wall St. Rank hold RGEN as of Q1 2017.
- IronBridge Capital Management held 212,822 shares of Repligen worth $7.49M as of Q1 2017.
- IronBridge Capital Management bought 90,830 Repligen shares in Q1 2017, an estimated $2.88M.
- Repligen made up 0.45% of IronBridge Capital Management's portfolio in Q1 2017, its #75 holding.
- IronBridge Capital Management first reported a position in Repligen in Q2 2016 and has held it in 4 quarters since.
- 180 funds tracked by Wall St. Rank held Repligen as of Q1 2017.
Based on IronBridge Capital Management's 13F filing for Q1 2017, filed 10 May 2017.